论文部分内容阅读
近10年来,世界植物药的发展取得了长足进步,一批传统草药经科学论证已晋升为法定药物。美国药典最新版(24版,2000年1月开始执行)迄今收载了25种植物药的约50种制剂,其中11种植物药约18种制剂是新收载的。为促进我国中药现代化、促进中草药及其制品的质量与现代国际要求接轨,本刊特请有关专家将美国药典24版收栽的植物药及其制剂的鉴别与质量标准译成中文,并在此栏目中陆续刊出,供我国中药生产企业、销售企业和药品监督管理机构参考。在此,本刊郑重声明:译文若与原文有出入,以原文为准。
In the past 10 years, great progress has been made in the development of botanical drugs in the world. A group of traditional herbs have been promoted to statutory drugs through scientific evidence. The latest edition of the United States Pharmacopeia (version 24, implemented since January 2000) contains up to date approximately 50 preparations of 25 botanicals, of which about 18 of the 11 botanicals are newly harvested. In order to promote the modernization of traditional Chinese medicine in China and to promote the quality of Chinese herbal medicine and its products in line with the requirements of the modern world, we hereby invite relevant experts to translate and identify the identification and quality standards of botanicals and their preparations collected in the 24th edition of the United States Pharmacopoeia Columns published one after another for our country’s traditional Chinese medicine manufacturing enterprises, marketing companies and drug regulatory agencies reference. Here, we solemnly declare: If the translation of the original text is different, the original text shall prevail.